Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

4.200 +0.680 (+19.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 264,866
Open 3.500
Bid (Size) 4.030 (200)
Ask (Size) 4.150 (500)
Prev. Close 3.520
Today's Range 3.457 - 4.270
52wk Range 3.030 - 9.329
Shares Outstanding 16,440,036
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sensus SRTS Q3 2025 Earnings Call Transcript
Sensus SRTS Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Sensus Healthcare Inc (NASDAQ:SRTS) Beats Q3 2025 Earnings Estimates Despite Revenue Decline
Sensus Healthcare (SRTS) beat Q3 2025 earnings estimates despite a revenue dip. The company highlighted a key regulatory win with new CPT codes for its skin cancer treatment technology. 
Via Chartmill

Performance

YTD
-40.8%
-40.8%
1 Month
+23.5%
+23.5%
3 Month
+32.1%
+32.1%
6 Month
-7.7%
-7.7%
1 Year
-38.0%
-38.0%

More News

Read More
Sensus Healthcare Reports Third Quarter 2025 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
From Sensus Healthcare, Inc.
Via Business Wire
Earnings Scheduled For November 6, 2025
Via Benzinga
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Announces the Passing of Director Bill McCall
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
From Sensus Healthcare, Inc.
Via Business Wire
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids
From Sensus Healthcare, Inc.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Sensus Healthcare, Inc. - Common Stock publicly traded?
Yes, Sensus Healthcare, Inc. - Common Stock is publicly traded.
What exchange does Sensus Healthcare, Inc. - Common Stock trade on?
Sensus Healthcare, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sensus Healthcare, Inc. - Common Stock?
The ticker symbol for Sensus Healthcare, Inc. - Common Stock is SRTS on the Nasdaq Stock Market
What is the current price of Sensus Healthcare, Inc. - Common Stock?
The current price of Sensus Healthcare, Inc. - Common Stock is 4.200
When was Sensus Healthcare, Inc. - Common Stock last traded?
The last trade of Sensus Healthcare, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Sensus Healthcare, Inc. - Common Stock?
The market capitalization of Sensus Healthcare, Inc. - Common Stock is 69.05M
How many shares of Sensus Healthcare, Inc. - Common Stock are outstanding?
Sensus Healthcare, Inc. - Common Stock has 69M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.